The article discusses the study conducted by Kim et al. which focuses on the benefits of the cycling of antibiotics on the reduction of mutational pathways towards resistance. Tackled is the genetic sequential of Staphylococcus aureus populations. The difference between the combination therapy and drug cycling is also explored.